Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Non Operating Income (2020 - 2025)

Bioventus' Non Operating Income history spans 6 years, with the latest figure at -$5.3 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 31.11% year-over-year to -$5.3 million; the TTM value through Dec 2025 reached -$6.8 million, up 81.8%, while the annual FY2025 figure was -$28.3 million, 23.91% up from the prior year.
  • Non Operating Income reached -$5.3 million in Q4 2025 per BVS's latest filing, down from -$79000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.5 million in Q2 2021 to a low of -$40.0 million in Q4 2023.
  • Average Non Operating Income over 5 years is -$5.6 million, with a median of -$2.1 million recorded in 2021.
  • Peak YoY movement for Non Operating Income: skyrocketed 2860.24% in 2021, then plummeted 1737.75% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $1.4 million in 2021, then tumbled by 792.21% to -$9.4 million in 2022, then plummeted by 324.55% to -$40.0 million in 2023, then skyrocketed by 80.59% to -$7.8 million in 2024, then soared by 31.11% to -$5.3 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Non Operating Income are -$5.3 million (Q4 2025), -$79000.0 (Q3 2025), and -$561000.0 (Q2 2025).